Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Other Non-Current Liabilities: 2022-2023

  • Therapeutics' Other Non-Current Liabilities was N/A to $871,000 in Q1 2023 from the same period last year, while for Mar 2023 it was $871,000, marking a year-over-year change of. This contributed to the annual value of $10.8 million for FY2022, which is N/A change from last year.
  • Per Therapeutics' latest filing, its Other Non-Current Liabilities stood at $871,000 for Q1 2023, which was down 91.95% from $10.8 million recorded in Q4 2022.
  • In the past 5 years, Therapeutics' Other Non-Current Liabilities registered a high of $10.8 million during Q4 2022, and its lowest value of $871,000 during Q1 2023.
  • Over the past 2 years, Therapeutics' median Other Non-Current Liabilities value was $2.4 million (recorded in 2022), while the average stood at $4.7 million.